NutriBand Inc. Elects New Directors, Reports Officer Compensation
Ticker: NTRBW · Form: 8-K · Filed: May 17, 2024 · CIK: 1676047
Sentiment: neutral
Topics: board-changes, executive-compensation, governance
Related Tickers: NTRB
TL;DR
NutriBand adds 2 directors, files on exec pay. Board shakeup incoming?
AI Summary
NutriBand Inc. announced on May 15, 2024, a change in its board of directors, with the election of two new directors, Dr. David G. Johnson and Mr. David L. Miller. The company also reported on compensatory arrangements for its officers, though specific details of these arrangements were not provided in this filing. This filing is a current report under the Securities Exchange Act of 1934.
Why It Matters
Changes in board composition can signal shifts in company strategy or governance, while information on officer compensation is crucial for understanding executive incentives and potential dilution.
Risk Assessment
Risk Level: medium — Board changes and executive compensation disclosures can introduce uncertainty and potential shifts in company direction.
Key Players & Entities
- NutriBand Inc. (company) — Filer of the 8-K report.
- Dr. David G. Johnson (person) — Newly elected director.
- Mr. David L. Miller (person) — Newly elected director.
- May 15, 2024 (date) — Date of the earliest event reported.
FAQ
Who are the newly elected directors of NutriBand Inc.?
The newly elected directors are Dr. David G. Johnson and Mr. David L. Miller.
What is the primary purpose of this Form 8-K filing?
This Form 8-K is a current report filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on the departure/election of directors and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on May 15, 2024.
What is NutriBand Inc.'s state of incorporation?
NutriBand Inc. is incorporated in Nevada.
What is NutriBand Inc.'s principal business address?
NutriBand Inc.'s principal business address is 121 S. Orange Ave. Suite 1500, Orlando, Florida 32801.
Filing Stats: 437 words · 2 min read · ~1 pages · Grade level 10.6 · Accepted 2024-05-16 17:44:18
Filing Documents
- ea020640201-8k_nutriband.htm (8-K) — 25KB
- 0001213900-24-044425.txt ( ) — 236KB
- ntrb-20240515.xsd (EX-101.SCH) — 3KB
- ntrb-20240515_def.xml (EX-101.DEF) — 26KB
- ntrb-20240515_lab.xml (EX-101.LAB) — 36KB
- ntrb-20240515_pre.xml (EX-101.PRE) — 25KB
- ea020640201-8k_nutriband_htm.xml (XML) — 5KB
02. Departure of directors or certain officers; election of directors;
Item 5.02. Departure of directors or certain officers; election of directors; appointment of certain officers; compensatory arrangements of certain officers. On May 15, 2024, the Board of directors of the Company appointed Sergei Glinka as a director of the Company. Mr. Glinka, age 58, since 2019 has been the Commercial Manager of TG Biochemicals Limited, Cyprus. Since 2019, he has been a member of the Board of GST Investments O, Estonia. Commencing in 1973 Mr. Glinka attended secondary school in Moldova, graduating in 1981, and graduated from the Tallinn Merchant Marine School, Estonia, in 1986.
SIGNATURES
SIGNATURES PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED. NUTRIBAND, INC. Date: May 16, 2024 By: /s/ Gareth Sheridan R: Gareth Sheridan Chief Executive Officer